Organization
HIV Vaccine Trials Network
4 clinical trials
Clinical trial
A Phase 2a Clinical Trial to Evaluate the Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living With and Without HIV in South AfricaStatus: Recruiting, Estimated PCD: 2024-11-30
Clinical trial
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Vaccines Based on Chimpanzee Serotypes of Adenovirus Expressing Clade C gp140 and a CH505TF gp120 Protein Boost in Healthy, HIV- Uninfected Adult ParticipantsStatus: Active (not recruiting), Estimated PCD: 2023-08-21
Clinical trial
A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected InfantsStatus: Active (not recruiting), Estimated PCD: 2024-08-20